Surmodics to Webcast First Quarter Fiscal 2019 Earnings Conference Call on January 30
January 22 2019 - 8:30AM
Business Wire
Webcast is Live at 4 p.m. (CT)
Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical
device and in vitro diagnostic technologies to the healthcare
industry, today announced that it will host a live webcast of its
first quarter fiscal 2019 conference call on Wednesday, January 30,
at 4 p.m. CT (5 p.m. ET). The Company will issue an earnings news
release after the market closes that afternoon.
Gary Maharaj, president and chief executive officer, and Tim
Arens, interim vice president of finance and chief financial
officer, will recap the first quarter fiscal 2019 financial results
and accomplishments. To access the webcast, go to the investor
relations portion of the Company’s website at
https://surmodics.gcs-web.com the day of the conference call and
click on the webcast icon.
An audio replay will be available beginning at 7 p.m. CT on
Wednesday, January 30, until 7 p.m. CT on Wednesday, February 6,
and can be accessed by dialing 888-203-1112 and entering conference
call ID passcode 1070221. In addition, the conference call audio
and transcript will be archived on the Company’s website following
the call.
About Surmodics, Inc.
Surmodics is the global leader in surface modification
technologies for intravascular medical devices and a
leading provider of chemical components for
in vitro diagnostic (IVD) immunoassay tests and
microarrays. Surmodics is pursuing highly differentiated
whole-product solutions that are designed to address unmet clinical
needs for its medical device customers and engineered to the most
demanding requirements. This key growth strategy
leverages the combination of the Company’s expertise
in proprietary surface technologies, along with enhanced
device design, development and manufacturing capabilities. The
Company mission remains to improve the detection and
treatment of disease. Surmodics is headquartered in Eden
Prairie, Minnesota. For more information, visit
www.surmodics.com. The content of Surmodics’ website is not
part of this press release or part of any filings that
the company makes with the SEC.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190122005219/en/
Tim Arens952-500-7000ir@surmodics.com
SurModics (NASDAQ:SRDX)
Historical Stock Chart
From Apr 2024 to May 2024
SurModics (NASDAQ:SRDX)
Historical Stock Chart
From May 2023 to May 2024